Anthracin 50 mg Injection (Epirubicin) — Broad-Spectrum Chemotherapy for Solid & Hematological Cancers Anthracin 50 mg Injection contains epirubicin hydrochloride, a potent anthracycline class chemotherapy medicine used in the treatment of multiple cancers, including breast cancer, lymphomas, leukemias, bladder carcinoma, and other solid tumours. Administered by intravenous (IV) infusion in hospital and oncology settings, epirubicin works by damaging cancer cell DNA, disrupting cell division, and leading to cancer cell death. Due to its strong effects and potential for significant side effects — such as bone marrow suppression, nausea, cardiotoxicity, and mucosal irritation — therapy with Anthracin requires careful clinical monitoring, including blood counts and heart function tests. Available in Pakistan through licensed oncology pharmacies and hospital drug stores with a valid doctor’s prescription, Anthracin 50 mg Injection is a key component of many combination chemotherapy regimens aimed at improving disease outcomes. Regular follow-up and supportive care are essential to ensure safe and effective treatment.